Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Moderna laid out sales expectations for the coming year on Monday that were below even the much-diminished Wall Street expectations. The stock was falling 14% to $35.71 in premarket trading. Monday’s ...

Biopharma executives were busy Monday, striking high-value deals and providing updates on cancer, obesity and vaccine ...

Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads ...

Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory ...

Moderna is the first US manufacturer to test its vaccine on infants. The company plans to enrol some 6,750 children in the US and Canada for the trial. The inoculation of children and young people ...

Covid-19 vaccine manufacturer Moderna has chosen a science campus as its UK base for the development of future medicines. The firm said the Innovation and Technology Centre would be built by the ...

Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Moderna and Pfizer are in talks with the federal ... “We continue to have active conversations with both manufacturers, and the negotiations are ongoing,” O’Connell said.

Scroll through the chart below to see which side effects are common based on your age group, which manufacturer's vaccine ... For Pfizer's and Moderna's two-shot vaccines, the second shot ...

A request by the NSW government to access Moderna’s mRNA facility to make animal vaccines was knocked back in 2022.